Atlantic Health Partners with Artera to Improve Colonoscopy Outreach

Artera's AI agents are being deployed to try to reach people who are at risk for colorectal cancer.

March 30, 2026

Key Highlights

Within 30 days, 43% of patients contacted by AI successfully confirmed their identities, demonstrating effective outreach.
39% of contacted patients committed to attending their upcoming colonoscopy, indicating increased appointment adherence.
7% of patients engaged with AI agents to ask questions about the procedure, reflecting improved patient education.
The AI system aims to reduce high cancellation and no-show rates associated with complex prep processes.
This initiative seeks to improve early detection of colorectal cancer, which has a high mortality rate if not diagnosed early.

Atlantic Health has partnered with Artera to deploy Artera’s AI technology to enhance colonoscopy patient outreach. PR Newswire has the release.

Colorectal cancer is “expected to claim the lives of more than 55,000 Americans in 2026,” yet “early-stage detection carries a survival rate of over 90 percent.” Nearly one-third of eligible adults remain unscreened despite this fact, “often due to the complexities of the multi-step preparation process.”

Within the first 30 days after the launch of this partnership, “43% of patients contacted by an AI agent successfully answered the phone calls and confirmed their identities;” “39% of patients confirmed that they will attend their upcoming colonoscopy appointments;” and “7% of patients asked the AI agent questions about the procedure.”

Colonoscopies traditionally have “high cancellation and no-show rates” because of the complex multi-day preparatory processes. The AI agents deployed by Artera aim to streamline that process in an attempt to “ensure higher procedure completion percentages and better overall health outcomes, in addition to consistent, standardized GI outreach, communication, and pre-appointment instructions across the entire organization.”